InvestorsHub Logo
Followers 10
Posts 362
Boards Moderated 0
Alias Born 06/22/2018

Re: Jasbg post# 347404

Monday, 07/19/2021 9:38:21 AM

Monday, July 19, 2021 9:38:21 AM

Post# of 425962
@marjac

Independent of what happened in the past, it is done now. Establishing a direct line to Karim to pursue all patent litigation option with the support of Amrn is the right path forward. Filing an amicus in support of Rul60/24 or whatever the company can do should be done.

Making the Reduce-It patent, skinny label a more national discussion across pharma to drum up support is the next thing

As US waits, putting forth a solid global strategy is the third thing.

Anything other than this is just a waste of time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News